Source comparison
BPC-157 vs Other Bone Healing Compounds
BPC-157 Upregulates VEGF and collagen synthesis at injury sites Animal models only. No human RCTs Experimental use for soft tissue and bone injuries Promising preclinical data but unverified in humans TB-500 (Thymosin Beta-4) Promotes actin polymerisation and
This comparison does not assign a generated winner or score.
- BPC-157
- Upregulates VEGF and collagen synthesis at injury sites
- Animal models only. No human RCTs
- Experimental use for soft tissue and bone injuries
- Promising preclinical data but unverified in humans
- TB-500 (Thymosin Beta-4)
- Promotes actin polymerisation and angiogenesis
- Limited human trials. Mostly animal data
- Soft tissue repair, tendon injuries
- Similar mechanism to BPC-157 with equally limited human evidence
- rhBMP-2 (Bone Morphogenetic Protein-2)
- Induces osteoblast differentiation directly
- FDA-approved for spinal fusion and tibial fractures
- Surgical bone grafting only
- Proven efficacy in controlled surgical settings. Not applicable to stress fractures
- Vitamin D3 + K2
- Supports calcium absorption and directs mineralisation
- Extensive clinical evidence
- Baseline bone health maintenance
- Essential but insufficient for accelerated fracture healing
- Collagen Peptides (Oral)
- Provides amino acid precursors for endogenous collagen synthesis
- Moderate evidence for connective tissue support
- General recovery nutrition
- Supports baseline repair but no evidence for accelerated healing